黑料吃瓜群网

Game-changing glove has built-in infection control


Friday, 15 June, 2018

Game-changing glove has built-in infection control

Medical examination gloves have a whole new layer of infection control.

A new type of glove has been developed with built-in antimicrobial technology that has been聽proven to prevent the spread of infection.

microbiologist Professor Emeritus Richard James has been working for several years on the project with medical glove maker and antimicrobial research and development company . Part of the glove鈥檚 testing was carried out in the Advanced Microscopy Unit at the University of Nottingham鈥檚 Centre for Biomolecular Science.

The gloves contain an active microorganism-killing molecule designed to prevent the spread of bacteria to and from surfaces and people. As the technology is built into the material, the gloves do not need surface applications of further solutions or chemicals.

In independent testing, the gloves achieved up to a 99.9% kill within just five minutes of contact.

鈥淭hese gloves will be a game changer for the healthcare industry, both public and private,鈥 said Professor James. 鈥淚 am delighted that my lifetime鈥檚 research into bacteria and antibiotic resistance has directly informed the science behind a practical tool that will have a major impact on medical care in the future.鈥

Professor Richard James. Image 漏University of Nottingham

鈥淚n the European Union alone, cross-contamination in hospitals results in 37,000 deaths a year at an additional cost of 鈧7 billion,鈥 said Kuan Mun Leong, Managing Director of . 鈥淏y renovating a medical device that has not been remodelled in over 30 years, our innovation is set to make waves in the healthcare industry and save lives across the globe.鈥

The product has been in the research and development phase for over six years, with millions of dollars of funding already being channelled into it and various stages of testing completed. The gloves will be available in hospitals around the world because the manufacturing partnership will make sure the product is being produced at a low cost in order to prevent barriers to access.

鈥淎fter years of development, we are delighted to finally release this product to market and truly believe it will make a significant difference in the fight against healthcare associated infections (HAIs),鈥 said Chemical Intelligence UK聽Founder Rob Gros. 鈥淟ike Hartalega, we have a passion for innovation and together we are the perfect partners to release this technology.鈥

Top image credit: 漏Chemical Intelligence UK/Hartalega

Originally published

Related News

Victoria's Q3 median ED wait times the lowest on record

Victoria's quarter three performance data (January–March) has shown improvement across...

Irregularities in a clinician's cases prompt 15-month lookback

St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...

Two researchers receive $899,000 in cardiovascular funding

In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...



Content from other channels on our network


  • All content Copyright 漏 2025 黑料吃瓜群网-Farrow Pty Ltd